Impact of a High-fiber Diet on the Microbiome and Disease Activity in Patients With Rheumatoid Arthritis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-99
SponsorWuerzburg University Hospital

About this trial

The goal of this clinical trial is to learn if increasing dietary fiber can improve the gut microbiome and reduce disease activity in adults with rheumatoid arthritis (RA). The main questions it aims to answer are:

* Can a higher fiber diet improve gut bacteria and produce beneficial short-chain fatty acids (SCFAs)? * Does a higher fiber diet reduce RA symptoms and help with weight loss?

Researchers will compare two groups: one group will receive dietary counseling and take 10 grams of psyllium husk daily, while the other group will continue their usual diet.

Participants will:

* Complete dietary questionnaires at the start, 6 months, and 12 months. * Provide stool samples for gut bacteria and SCFA analysis. * Have their RA activity and body weight monitored regularly. * Receive regular phone calls to support the dietary changes.

The study will involve adults with diagnosed RA who can provide informed consent and meet other inclusion criteria.

Eligibility criteria

Qualifiers

Patients over 18 years old

Diagnosis of Rheumatoid Arthritis according to the ACR criteria of 2010

The patient can understand the scope of the study and consents in writing to participate.

Disqualifiers

Age under 18

Lack of consent capability

Insufficient knowledge of the German language

Chronic inflammatory bowel disease

Trial design

Treatments tested in this trial

  • Psyllium husks

Treatment groups

52 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Wuerzburg University Hospital

Lead sponsor

RheinNatur Food GmbH

Collaborator